JAMES TUCKER: Open Payments
NPI 1851772289 · HANNIBAL, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,235 in 64 payments from 18 companies in 2025. Trend: 2023 $1,356 · 2024 $1,082 · 2025 $1,235
Food & beverage: $1,235
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $242 |
| ABBVIE INC. | 13 | $160 |
| Amgen Inc. | 12 | $157 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $101 |
| HARMONY BIOSCIENCES LLC | 1 | $91 |
| PFIZER INC. | 4 | $88 |
| Verona Pharma, Inc. | 4 | $76 |
| Neurocrine BioSciences, Inc. | 3 | $62 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Lundbeck LLC | 2 | $34 |
Products named: AIRSUPRA, OTEZLA, CAPLYTA, WAKIX, Ohtuvayre, VRAYLAR, INGREZZA, QULIPTA.
Industry payments across MO — which companies pay providers there.
